Forecasting off-target drug toxicity using proteomic and genetic data: insights from Torcetrapib.

Summary: Creating new medicines is incredibly difficult and expensive. Sometimes, drugs that look great in the lab end up causing unexpected harm—like raising blood pressure—when given to real people. This happened with a cholesterol drug called Torcetrapib. Now, scientists have found a clever way to predict these bad side effects early on. By looking at a person's genes and the proteins in their blood, researchers can spot warning signs before running massive, costly tests on humans. This new method could save billions of dollars and keep patients much safer in the future!